Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in the Middle East: a report from the Global Opioid Policy Initiative (GOPI)
The Middle East is a heterogeneous region with substantial variability in social development, wealth and palliative care development. The region has few democracies, strong but diverse religious affiliations, and many of the region's counties are involved in political upheavals or regional conf...
Gespeichert in:
| Veröffentlicht in: | Annals of oncology 2013-12, Vol.24 Suppl 11, p.xi51-xi59 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | xi59 |
|---|---|
| container_issue | |
| container_start_page | xi51 |
| container_title | Annals of oncology |
| container_volume | 24 Suppl 11 |
| creator | Cleary, J Silbermann, M Scholten, W Radbruch, L Torode, J Cherny, N I |
| description | The Middle East is a heterogeneous region with substantial variability in social development, wealth and palliative care development. The region has few democracies, strong but diverse religious affiliations, and many of the region's counties are involved in political upheavals or regional conflicts. While the global consumption of opioids has increased throughout the last 30 years, there has been little increase in opioid consumption in the Middle East. This is the first comprehensive study of opioid availability and accessibility of opioids in the Middle East. Data are reported on the availability and accessibility of opioids for the management of cancer pain in 16 of 24 countries. The data are relevant to 329 million of the region's 403 million people (82%). The survey found that with the exception of Israel, opioid availability continues to be low throughout most of the Middle East. Formulary deficiencies are severe in several countries in particular Afghanistan, Iraq, Lebanon, Libya, Palestine and Tunisia. Even when opioids are on formulary, they are often unavailable, particularly in these same countries. Access is also significantly impaired by widespread over-regulation that is pervasive across the region. |
| doi_str_mv | 10.1093/annonc/mdt503 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1465861832</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1465861832</sourcerecordid><originalsourceid>FETCH-LOGICAL-c332t-7abe0f0721f87babb54141d4dd3f6e4e1ad0c9b428149fb019302fa5ceb388d63</originalsourceid><addsrcrecordid>eNo9kU1r3DAQhkVpaDZpj72WOaYHN_qy1-6thGSzkLA5tGcz-mpVZMuVtIH8ov7NKNltQTCI9-GBmZeQj4x-YXQQlzjPcdaXkyktFW_IirXd0PRUsrdkRQcumnUr5Ck5y_k3pbQb-PCOnHLJ-5YLuiJ_b2Ka9gHTE-Aj-oDKB1_qZzaQ7M-alFgzhSl5mzKUCKi1zdkfweggLj56k8HFBBpnbRMs6Geor_yycO-NCRauMZevgNW6xFTApTi9xpsQFQbYvUrgIQavn2A7--Kx-EcLF5vdw_bze3LiMGT74TjPyY-b6-9Xt83dbrO9-nbXaCF4adaoLHV0zZnr1wqVaiWTzEhjhOustAwN1YOq6zM5OEXZICh32GqrRN-bTpyTi4N3SfHP3uYyTj5rGwLONu7zyGTX9h3rBa9oc0B1ijkn68Yl-alecmR0fOlmPHQzHrqp_Kejeq8ma_7T_8oQz0sGj2o</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1465861832</pqid></control><display><type>article</type><title>Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in the Middle East: a report from the Global Opioid Policy Initiative (GOPI)</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Cleary, J ; Silbermann, M ; Scholten, W ; Radbruch, L ; Torode, J ; Cherny, N I</creator><creatorcontrib>Cleary, J ; Silbermann, M ; Scholten, W ; Radbruch, L ; Torode, J ; Cherny, N I</creatorcontrib><description>The Middle East is a heterogeneous region with substantial variability in social development, wealth and palliative care development. The region has few democracies, strong but diverse religious affiliations, and many of the region's counties are involved in political upheavals or regional conflicts. While the global consumption of opioids has increased throughout the last 30 years, there has been little increase in opioid consumption in the Middle East. This is the first comprehensive study of opioid availability and accessibility of opioids in the Middle East. Data are reported on the availability and accessibility of opioids for the management of cancer pain in 16 of 24 countries. The data are relevant to 329 million of the region's 403 million people (82%). The survey found that with the exception of Israel, opioid availability continues to be low throughout most of the Middle East. Formulary deficiencies are severe in several countries in particular Afghanistan, Iraq, Lebanon, Libya, Palestine and Tunisia. Even when opioids are on formulary, they are often unavailable, particularly in these same countries. Access is also significantly impaired by widespread over-regulation that is pervasive across the region.</description><identifier>ISSN: 0923-7534</identifier><identifier>EISSN: 1569-8041</identifier><identifier>DOI: 10.1093/annonc/mdt503</identifier><identifier>PMID: 24285230</identifier><language>eng</language><publisher>England</publisher><subject>Analgesics, Opioid - therapeutic use ; Health Education ; Health Knowledge, Attitudes, Practice ; Health Policy - legislation & jurisprudence ; Health Services Accessibility - legislation & jurisprudence ; Humans ; Middle East ; Morphine - therapeutic use ; Neoplasms - drug therapy ; Pain - drug therapy ; Pain Management - methods ; Palliative Care</subject><ispartof>Annals of oncology, 2013-12, Vol.24 Suppl 11, p.xi51-xi59</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c332t-7abe0f0721f87babb54141d4dd3f6e4e1ad0c9b428149fb019302fa5ceb388d63</citedby><cites>FETCH-LOGICAL-c332t-7abe0f0721f87babb54141d4dd3f6e4e1ad0c9b428149fb019302fa5ceb388d63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,778,782,27907,27908</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24285230$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cleary, J</creatorcontrib><creatorcontrib>Silbermann, M</creatorcontrib><creatorcontrib>Scholten, W</creatorcontrib><creatorcontrib>Radbruch, L</creatorcontrib><creatorcontrib>Torode, J</creatorcontrib><creatorcontrib>Cherny, N I</creatorcontrib><title>Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in the Middle East: a report from the Global Opioid Policy Initiative (GOPI)</title><title>Annals of oncology</title><addtitle>Ann Oncol</addtitle><description>The Middle East is a heterogeneous region with substantial variability in social development, wealth and palliative care development. The region has few democracies, strong but diverse religious affiliations, and many of the region's counties are involved in political upheavals or regional conflicts. While the global consumption of opioids has increased throughout the last 30 years, there has been little increase in opioid consumption in the Middle East. This is the first comprehensive study of opioid availability and accessibility of opioids in the Middle East. Data are reported on the availability and accessibility of opioids for the management of cancer pain in 16 of 24 countries. The data are relevant to 329 million of the region's 403 million people (82%). The survey found that with the exception of Israel, opioid availability continues to be low throughout most of the Middle East. Formulary deficiencies are severe in several countries in particular Afghanistan, Iraq, Lebanon, Libya, Palestine and Tunisia. Even when opioids are on formulary, they are often unavailable, particularly in these same countries. Access is also significantly impaired by widespread over-regulation that is pervasive across the region.</description><subject>Analgesics, Opioid - therapeutic use</subject><subject>Health Education</subject><subject>Health Knowledge, Attitudes, Practice</subject><subject>Health Policy - legislation & jurisprudence</subject><subject>Health Services Accessibility - legislation & jurisprudence</subject><subject>Humans</subject><subject>Middle East</subject><subject>Morphine - therapeutic use</subject><subject>Neoplasms - drug therapy</subject><subject>Pain - drug therapy</subject><subject>Pain Management - methods</subject><subject>Palliative Care</subject><issn>0923-7534</issn><issn>1569-8041</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9kU1r3DAQhkVpaDZpj72WOaYHN_qy1-6thGSzkLA5tGcz-mpVZMuVtIH8ov7NKNltQTCI9-GBmZeQj4x-YXQQlzjPcdaXkyktFW_IirXd0PRUsrdkRQcumnUr5Ck5y_k3pbQb-PCOnHLJ-5YLuiJ_b2Ka9gHTE-Aj-oDKB1_qZzaQ7M-alFgzhSl5mzKUCKi1zdkfweggLj56k8HFBBpnbRMs6Geor_yycO-NCRauMZevgNW6xFTApTi9xpsQFQbYvUrgIQavn2A7--Kx-EcLF5vdw_bze3LiMGT74TjPyY-b6-9Xt83dbrO9-nbXaCF4adaoLHV0zZnr1wqVaiWTzEhjhOustAwN1YOq6zM5OEXZICh32GqrRN-bTpyTi4N3SfHP3uYyTj5rGwLONu7zyGTX9h3rBa9oc0B1ijkn68Yl-alecmR0fOlmPHQzHrqp_Kejeq8ma_7T_8oQz0sGj2o</recordid><startdate>20131201</startdate><enddate>20131201</enddate><creator>Cleary, J</creator><creator>Silbermann, M</creator><creator>Scholten, W</creator><creator>Radbruch, L</creator><creator>Torode, J</creator><creator>Cherny, N I</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20131201</creationdate><title>Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in the Middle East: a report from the Global Opioid Policy Initiative (GOPI)</title><author>Cleary, J ; Silbermann, M ; Scholten, W ; Radbruch, L ; Torode, J ; Cherny, N I</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c332t-7abe0f0721f87babb54141d4dd3f6e4e1ad0c9b428149fb019302fa5ceb388d63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Analgesics, Opioid - therapeutic use</topic><topic>Health Education</topic><topic>Health Knowledge, Attitudes, Practice</topic><topic>Health Policy - legislation & jurisprudence</topic><topic>Health Services Accessibility - legislation & jurisprudence</topic><topic>Humans</topic><topic>Middle East</topic><topic>Morphine - therapeutic use</topic><topic>Neoplasms - drug therapy</topic><topic>Pain - drug therapy</topic><topic>Pain Management - methods</topic><topic>Palliative Care</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cleary, J</creatorcontrib><creatorcontrib>Silbermann, M</creatorcontrib><creatorcontrib>Scholten, W</creatorcontrib><creatorcontrib>Radbruch, L</creatorcontrib><creatorcontrib>Torode, J</creatorcontrib><creatorcontrib>Cherny, N I</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Annals of oncology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cleary, J</au><au>Silbermann, M</au><au>Scholten, W</au><au>Radbruch, L</au><au>Torode, J</au><au>Cherny, N I</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in the Middle East: a report from the Global Opioid Policy Initiative (GOPI)</atitle><jtitle>Annals of oncology</jtitle><addtitle>Ann Oncol</addtitle><date>2013-12-01</date><risdate>2013</risdate><volume>24 Suppl 11</volume><spage>xi51</spage><epage>xi59</epage><pages>xi51-xi59</pages><issn>0923-7534</issn><eissn>1569-8041</eissn><abstract>The Middle East is a heterogeneous region with substantial variability in social development, wealth and palliative care development. The region has few democracies, strong but diverse religious affiliations, and many of the region's counties are involved in political upheavals or regional conflicts. While the global consumption of opioids has increased throughout the last 30 years, there has been little increase in opioid consumption in the Middle East. This is the first comprehensive study of opioid availability and accessibility of opioids in the Middle East. Data are reported on the availability and accessibility of opioids for the management of cancer pain in 16 of 24 countries. The data are relevant to 329 million of the region's 403 million people (82%). The survey found that with the exception of Israel, opioid availability continues to be low throughout most of the Middle East. Formulary deficiencies are severe in several countries in particular Afghanistan, Iraq, Lebanon, Libya, Palestine and Tunisia. Even when opioids are on formulary, they are often unavailable, particularly in these same countries. Access is also significantly impaired by widespread over-regulation that is pervasive across the region.</abstract><cop>England</cop><pmid>24285230</pmid><doi>10.1093/annonc/mdt503</doi><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0923-7534 |
| ispartof | Annals of oncology, 2013-12, Vol.24 Suppl 11, p.xi51-xi59 |
| issn | 0923-7534 1569-8041 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1465861832 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection |
| subjects | Analgesics, Opioid - therapeutic use Health Education Health Knowledge, Attitudes, Practice Health Policy - legislation & jurisprudence Health Services Accessibility - legislation & jurisprudence Humans Middle East Morphine - therapeutic use Neoplasms - drug therapy Pain - drug therapy Pain Management - methods Palliative Care |
| title | Formulary availability and regulatory barriers to accessibility of opioids for cancer pain in the Middle East: a report from the Global Opioid Policy Initiative (GOPI) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-16T19%3A29%3A57IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Formulary%20availability%20and%20regulatory%20barriers%20to%20accessibility%20of%20opioids%20for%20cancer%20pain%20in%20the%20Middle%20East:%20a%20report%20from%20the%20Global%20Opioid%20Policy%20Initiative%20(GOPI)&rft.jtitle=Annals%20of%20oncology&rft.au=Cleary,%20J&rft.date=2013-12-01&rft.volume=24%20Suppl%2011&rft.spage=xi51&rft.epage=xi59&rft.pages=xi51-xi59&rft.issn=0923-7534&rft.eissn=1569-8041&rft_id=info:doi/10.1093/annonc/mdt503&rft_dat=%3Cproquest_cross%3E1465861832%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1465861832&rft_id=info:pmid/24285230&rfr_iscdi=true |